Self-administered psychological programs for treating irritable bowel syndrome

Desarrollo de Programas de intervención psicológica Autoadministrable Con Soporte de Nuevas tecnologías Como Tratamiento Para Pacientes Con Trastornos Funcionales Digestivos.

NA · Hospital Universitari Vall d'Hebron Research Institute · NCT06318572

This study is testing whether virtual reality programs can help people with irritable bowel syndrome manage their symptoms and improve their overall well-being from the comfort of their homes.

Quick facts

PhaseNA
Study typeInterventional
Enrollment100 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorHospital Universitari Vall d'Hebron Research Institute (other)
Locations1 site (Barcelona)
Trial IDNCT06318572 on ClinicalTrials.gov

What this trial studies

This study aims to evaluate the effectiveness of innovative psychological interventions delivered through virtual reality technology for patients suffering from functional digestive disorders, particularly irritable bowel syndrome. The approach focuses on using telematic methods to provide psycho-educational support at home, addressing symptoms severity, comorbidities, visceral sensitivity, and intestinal dysbiosis. By leveraging technology, the study seeks to overcome the barriers of limited access to traditional psychological therapies for these common conditions.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals with a BMI between 18.5-24.99 who can understand and follow instructions and have access to the internet.

Not a fit: Patients with a history of major psychiatric disorders or significant organic gastrointestinal pathology may not benefit from this study.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the quality of life for patients with irritable bowel syndrome by providing accessible psychological support.

How similar studies have performed: Previous studies have shown that psychological interventions like cognitive behavioral therapy can be beneficial for managing similar disorders, indicating a promising avenue for this novel approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI (Body Mass Index) between 18.5-24.99, with variations of up to 15%.
* Ability to understand instructions and follow protocol.
* Access to internet network from usual residence.

Exclusion Criteria:

* Previous history of abdominal surgery with the exception of appendectomy and herniorrhaphy.
* Abuse of alcohol, tobacco or narcotics.
* Medical evidence of organic gastrointestinal pathology, hepatopathy, endocrinopathy, heart disease or contagious disease, as well as major psychiatric disorder.

Where this trial is running

Barcelona

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Irritable Bowel Syndrome

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.